Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Makena: Professional Societies Finally See Eye To Eye With US FDA’s Drugs Center
Apr 10 2023
•
By
Sue Sutter
ACOG and SMFM altered their clinical recommendations on Makena only after the FDA's withdrawal order came down. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Post-Marketing Regulation & Studies
More from Product Reviews